Gabrilovich DI - Search Results

1

Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells.

Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele L, Gabrilovich DI. Cheng P, et al. Among authors: gabrilovich di. J Immunol. 2001 Oct 15;167(8):4458-67. doi: 10.4049/jimmunol.167.8.4458. J Immunol. 2001. PMID: 11591772

2

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.

Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP, Gabrilovich DI. Oyama T, et al. Among authors: gabrilovich di. J Immunol. 1998 Feb 1;160(3):1224-32. J Immunol. 1998. PMID: 9570538

3

Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.

Ohm JE, Shurin MR, Esche C, Lotze MT, Carbone DP, Gabrilovich DI. Ohm JE, et al. Among authors: gabrilovich di. J Immunol. 1999 Sep 15;163(6):3260-8. J Immunol. 1999. PMID: 10477595

4

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.

Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI. Almand B, et al. Among authors: gabrilovich di. J Immunol. 2001 Jan 1;166(1):678-89. doi: 10.4049/jimmunol.166.1.678. J Immunol. 2001. PMID: 11123353

5

Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.

Dikov MM, Oyama T, Cheng P, Takahashi T, Takahashi K, Sepetavec T, Edwards B, Adachi Y, Nadaf S, Daniel T, Gabrilovich DI, Carbone DP. Dikov MM, et al. Among authors: gabrilovich di. Cancer Res. 2001 Mar 1;61(5):2015-21. Cancer Res. 2001. PMID: 11280761

6

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.

Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Gabrilovich DI, et al. J Immunol. 2001 May 1;166(9):5398-406. doi: 10.4049/jimmunol.166.9.5398. J Immunol. 2001. PMID: 11313376

7

H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors.

Gabrilovich DI, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP, Skoultchi AI. Gabrilovich DI, et al. J Leukoc Biol. 2002 Aug;72(2):285-96. J Leukoc Biol. 2002. PMID: 12149419

8

Notch signaling is necessary but not sufficient for differentiation of dendritic cells.

Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Cheng P, et al. Blood. 2003 Dec 1;102(12):3980-8. doi: 10.1182/blood-2003-04-1034. Epub 2003 Aug 7. Blood. 2003. PMID: 12907456 Free article.

9

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Nefedova Y, et al. Among authors: gabrilovich di. Blood. 2004 May 1;103(9):3503-10. doi: 10.1182/blood-2003-07-2340. Epub 2003 Dec 11. Blood. 2004. PMID: 14670925 Free article.

10

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Nefedova Y, et al. J Immunol. 2004 Jan 1;172(1):464-74. doi: 10.4049/jimmunol.172.1.464. J Immunol. 2004. PMID: 14688356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters